IKONIK TONIK

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
IKONIK TONIK
Generic name
LIDOCAINE HYDROCHLORIDE
Manufacturer
IKONIK CARE, LLC
Product type
HUMAN OTC DRUG
SPL set ID
122fdfe8-b5fa-46d1-9fd9-3df9887ed320
SPL ID
a30cc8cf-1348-46ef-b903-b24ca134228a
Version
1
Effective date
2025-01-14
Source export date
2026-11-06
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/b00a73f24c6ff050408c570063640e3d80d1f71dfc9a165d1cf072a25659445a/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 07:02:20
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use in large quantities, particularly over • raw surfaces • blistered areas • deep puncture wounds • serious burns When using this product • avoid contact with the eyes, mouth or mucous membranes • avoid excessive use or prolonged application. Overuse may lead to increased risk of side effects Stop use and ask a doctor if • condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days • allergic reaction occurs, or if redness, irritation, swelling, pain or other symptoms begin to increase If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.